Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy
S Gaujoux, A Cortes, A Couvelard, S Noullet, L Clavel… - Surgery, 2010 - Elsevier
BACKGROUND: Pancreatic fistula (PF) after pancreatoduodenectomy (PD) remains a
challenging problem. The only commonly accepted risk factor is the soft consistency of the …
challenging problem. The only commonly accepted risk factor is the soft consistency of the …
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01
…, BL Asselin, RD Barr, LA Clavell… - Blood, The Journal …, 2001 - ashpublications.org
The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium
Protocol 91-01 was designed to improve the outcome of children with newly diagnosed ALL …
Protocol 91-01 was designed to improve the outcome of children with newly diagnosed ALL …
[HTML][HTML] The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
…, BL Asselin, RD Barr, LA Clavell… - … England Journal of …, 2004 - Mass Medical Soc
Background Doxorubicin chemotherapy is very effective in children with acute lymphoblastic
leukemia (ALL) but also injures myocardial cells. Dexrazoxane, a free-radical scavenger, …
leukemia (ALL) but also injures myocardial cells. Dexrazoxane, a free-radical scavenger, …
Incidence of venous thromboembolism in patients with newly diagnosed pancreatic cancer and factors associated with outcomes
…, R Gincul, P Artru, L Clavel, AI Lemaistre, L Palazzo… - Gastroenterology, 2020 - Elsevier
… in compliance with the Helsinki Declaration and approved by (1) the National Committee
for Data Processing related to health research (Comité Consultatif sur le Traitement de l’…
for Data Processing related to health research (Comité Consultatif sur le Traitement de l’…
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia
A Moghrabi, DE Levy, B Asselin, R Barr, L Clavell… - Blood, 2007 - ashpublications.org
… × 10 9 /L and platelet nadirs of 75 to 100 × 10 9 /L. Doses were reduced for mucositis and
transaminitis. Maximum doses were 40 mg/m 2 /wk for methotrexate and 75 mg/m 2 /d for 6-…
transaminitis. Maximum doses were 40 mg/m 2 /wk for methotrexate and 75 mg/m 2 /d for 6-…
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective …
…, EV Barry, BL Asselin, U Athale, LA Clavell… - The lancet …, 2010 - thelancet.com
Background Doxorubicin chemotherapy is associated with cardiomyopathy. Dexrazoxane
reduces cardiac damage during treatment with doxorubicin in children with acute …
reduces cardiac damage during treatment with doxorubicin in children with acute …
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia
LA Clavell, RD Gelber, HJ Cohen… - New England journal …, 1986 - Mass Medical Soc
We prospectively assigned 289 consecutive children with acute lymphoblastic leukemia to
receive one of two treatment programs on the basis of the presence or absence of certain risk …
receive one of two treatment programs on the basis of the presence or absence of certain risk …
Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985–2000)
…, JE O'Brien, BL Asselin, RD Barr, L Clavell… - Leukemia, 2010 - nature.com
The Dana-Farber Cancer Institute (DFCI) acute lymphoblastic leukemia (ALL) Consortium
has been conducting multi-institutional clinical trials in childhood ALL since 1981. The …
has been conducting multi-institutional clinical trials in childhood ALL since 1981. The …
[HTML][HTML] Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term …
…, BL Asselin, UH Athale, LA Clavell… - Journal of clinical …, 2012 - ncbi.nlm.nih.gov
… Levels of hsCRP were determined by using the Tina-quant C-reactive protein [latex] high-sensitive
assay (Roche Diagnostics, Indianapolis, IN; sensitivity, 0.03 mg/L). Levels of NT-proBNP …
assay (Roche Diagnostics, Indianapolis, IN; sensitivity, 0.03 mg/L). Levels of NT-proBNP …
A generic framework for scenario exercises using models applied to water-resource management
… c d , Jacques-Eric Bergez a b , Lucie Clavel a b , Véronique Masson e , Pierre Moreau c d
… What management practices should be promoted to reach a nitrate concentration of 10 mg/l…
… What management practices should be promoted to reach a nitrate concentration of 10 mg/l…
